C3.ai shares are back at price levels investors haven’t seen since early 2023, and the reasons are downright concerning.
The artificial intelligence firm with ticker AI has endured a brutal year that began in January when the share price was cut in half. The torpedos keeping hitting the bow, as evidence by the latest business update that pointed to a steep revenue shortfall.
» Read more about: Is The Stock with Ticker AI Finally a Buy? »
Thermo Fisher Scientific has a knack for thriving even in challenging markets. While the company isn’t entirely immune to today’s global headwinds, slower biopharmaceutical spending, tighter budgets in academic labs, and muted demand in China, it has weathered the storm far better than most of its peers.
The reason?
A combination of unmatched scale,
» Read more about: 1 Science Powerhouse To Own for the Next Decade »
Over the last five years, Altria’s share price climbed by just over 50%, but that’s only part of the story. When you factor in dividends, a payout the company has raised for 55 consecutive years, total returns swell to over 120%.
That streak includes 59 separate payout bumps, and with today’s yield hovering around 6.36%,
» Read more about: Can This Stock Double Your Money by 2030? »
This year, nuclear energy stocks have been some of the market’s best performers. Small modular reactor (SMR) developers like NuScale Power (SMR) and Oklo (OKLO) have been announcing a steady stream of partnerships, and Donald Trump, has pushed fresh executive orders aimed at accelerating the sector’s development.
Investors have plenty of reason to be excited but a surprising new catalyst has emerged,
» Read more about: Why Nuclear’s Next Frontier Could Be 240,000 Miles Away »
For more than half a decade, Warren Buffett’s Berkshire Hathaway accumulated the same stock quarter after quarter, 23 straight times, to be exact. Then, without warning, the buying stopped last year.
It wasn’t because Buffett lost faith in the company. In fact, his recent moves suggest he’s been biding his time, waiting for the numbers and the price to line up again.
» Read more about: Will Buffett’s 23-Quarter Streak Start Again? »
Apple shares climbed late last week on Wall Street’s growing belief that the company may have defused one of its biggest political risks, the ongoing tariff standoff with the Trump administration.
The breakthrough comes after Apple announced an eye-popping $600 billion investment in the United States, a figure that instantly turned heads in Washington and on Wall Street.
Lip-Bu Tan hasn’t been in the driver’s seat at Intel for long, but the new CEO is already making it clear that the era of open-ended spending is over. If Intel’s bleeding-edge chip manufacturing can’t justify its existence with real customer demand, it won’t get more money, period.
That kind of financial discipline might sound like corporate buzzkill,
» Read more about: This Move Might Reshape the Future of the Chip Industry »
AI might be the future, but that future has a power problem. For all the fanfare surrounding generative AI, one inconvenient truth continues to lurk in the background, which is it consumes an extraordinary amount of energy.
And unless someone cracks the code on power efficiency, scaling AI beyond the data center and into billions of edge devices will remain an expensive dream.
» Read more about: Is Ambiq the Answer to AI’s Biggest Blind Spot? »
Birkenstock sandals may be designed for comfort, but since going public, Birkenstock stock (NYSE: BIRK) has delivered more of a roller coaster than a relaxing stroll.
Over the past 12 months, shares have swung from gains in the mid-teens to losses twice that size, and as of today, they’re sitting roughly 8% in the red.
» Read more about: Birkenstock Is Bouncing, Should Long-Term Investors Stay the Course? »
Walk into just about any town in America, and chances are you’ll spot a Walgreens. The pharmacy chain is one of the most ubiquitous retail brands in the country, with over 8,000 locations across the U.S. alone.
But while its storefronts are everywhere, the same can’t be said for investor confidence in its stock.